MICHELETTO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.639
AS - Asia 929
EU - Europa 396
AF - Africa 126
SA - Sud America 121
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 3.235
Nazione #
US - Stati Uniti d'America 1.564
SG - Singapore 374
CN - Cina 157
VN - Vietnam 118
IT - Italia 79
BR - Brasile 69
HK - Hong Kong 62
IE - Irlanda 37
DE - Germania 34
IN - India 33
FI - Finlandia 30
FR - Francia 30
PL - Polonia 25
TR - Turchia 18
GB - Regno Unito 17
BD - Bangladesh 16
RU - Federazione Russa 15
CH - Svizzera 12
IQ - Iraq 12
NL - Olanda 11
AR - Argentina 10
CO - Colombia 10
JP - Giappone 10
PH - Filippine 10
SE - Svezia 10
BZ - Belize 9
ES - Italia 9
KR - Corea 8
LV - Lettonia 8
RE - Reunion 8
TN - Tunisia 8
UA - Ucraina 8
VE - Venezuela 8
LA - Repubblica Popolare Democratica del Laos 7
NO - Norvegia 7
ZA - Sudafrica 7
AT - Austria 6
AU - Australia 6
CA - Canada 6
CI - Costa d'Avorio 6
DK - Danimarca 6
IL - Israele 6
IR - Iran 6
PK - Pakistan 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
UZ - Uzbekistan 6
BO - Bolivia 5
CG - Congo 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HN - Honduras 5
ID - Indonesia 5
LC - Santa Lucia 5
MX - Messico 5
MY - Malesia 5
NP - Nepal 5
PR - Porto Rico 5
PT - Portogallo 5
SA - Arabia Saudita 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BF - Burkina Faso 4
CU - Cuba 4
EE - Estonia 4
GM - Gambi 4
GP - Guadalupe 4
HU - Ungheria 4
KE - Kenya 4
KG - Kirghizistan 4
LY - Libia 4
MA - Marocco 4
NA - Namibia 4
PA - Panama 4
PS - Palestinian Territory 4
RS - Serbia 4
RW - Ruanda 4
XK - ???statistics.table.value.countryCode.XK??? 4
YT - Mayotte 4
AL - Albania 3
BG - Bulgaria 3
CL - Cile 3
EC - Ecuador 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
GH - Ghana 3
GN - Guinea 3
GR - Grecia 3
GT - Guatemala 3
HT - Haiti 3
JO - Giordania 3
KH - Cambogia 3
LB - Libano 3
LU - Lussemburgo 3
MD - Moldavia 3
MR - Mauritania 3
MW - Malawi 3
Totale 3.124
Città #
Singapore 268
San Jose 182
Woodbridge 158
Ashburn 134
Fairfield 124
Ann Arbor 121
Chandler 116
Houston 91
Santa Clara 78
Hong Kong 54
Wilmington 48
Seattle 41
Cambridge 40
Dong Ket 40
Dublin 34
Boardman 29
Los Angeles 29
Beijing 26
Guangzhou 25
Ho Chi Minh City 22
Council Bluffs 21
Des Moines 21
Princeton 21
Bytom 20
Jacksonville 18
Roxbury 17
San Diego 17
Hanoi 15
Lauterbourg 15
Medford 15
Nanjing 15
Helsinki 12
São Paulo 11
Baghdad 8
Belize City 8
Brooklyn 7
Pohang 7
Riga 7
Abidjan 6
Ankara 6
Bristol 6
Buffalo 6
Cagliari 6
Milan 6
New York 6
Redondo Beach 6
Shenyang 6
Tashkent 6
Castries 5
Nanchang 5
Padova 5
Quezon City 5
San José 5
Tunis 5
Turin 5
Verona 5
Atlanta 4
Baku 4
Bangkok 4
Banjul 4
Bishkek 4
Changsha 4
Frankfurt am Main 4
Havana 4
Kigali 4
La Paz 4
Mamoudzou 4
Montevideo 4
New Delhi 4
Ouagadougou 4
Shanghai 4
Stockholm 4
Tallinn 4
Tripoli 4
Vientiane 4
Warsaw 4
Addis Ababa 3
Algiers 3
Amman 3
Athens 3
Bergamo 3
Chennai 3
Conakry 3
Copenhagen 3
Dakar 3
Dar es Salaam 3
Dhaka 3
Harare 3
Istanbul 3
Jiaxing 3
Kingstown 3
Libreville 3
Lilongwe 3
Lima 3
Mumbai 3
Nairobi 3
Nouakchott 3
Orem 3
Oslo 3
Panama City 3
Totale 2.167
Nome #
In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes 237
The UVA/PADOVA Type 1 Diabetes Simulator: New Features. 223
A model of beta-cell response to GLP-1 to quantify incretin effect in healthy and prediabetic subjects 223
The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. 218
Model-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge 217
A model of GLP-1 action on insulin secretion in nondiabetic subjects. 211
A Model of GLP-1 Action on Insulin Secretion in Nondiabetic Subjects 203
Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. 201
Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. 201
Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass 179
A Counter-Regulation Model in Type 1 Diabetes 175
Six and 12 Weeks of Caloric Restriction Increases beta Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes 173
PREDIABETES AND TYPE 2 DIABETES SIMULATOR: IN SILICO TESTING OF NEW DRUGS. DIABETES TECHNOLOGY & THERAPEUTICS 155
A Model of GLP-1 Action on Insulin Secretion during an Oral Test 139
The Updated UVA/Padova Type 1 Diabetes Simulator 137
Modeling The Effect Of Pramlintide On Meal Glucose Rate Of Appearance In Health. Advanced Technologies & Treatments for Diabetes 132
In Silico Modeling for Clinical Trial Optimization 112
In Silico Determination of a Pramlintide-Insulin Ratio for Co-Administration in Type 1 Diabetes (T1D) 104
Totale 3.240
Categoria #
all - tutte 8.446
article - articoli 5.648
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 12 50
2021/2022219 5 33 22 20 3 7 9 24 3 5 14 74
2022/2023251 45 28 20 15 47 44 3 12 24 0 9 4
2023/2024125 8 13 23 11 1 0 7 19 2 20 5 16
2024/2025449 8 93 19 9 103 14 16 5 19 10 79 74
2025/20261.452 50 84 198 228 168 70 174 132 182 109 57 0
Totale 3.240